TWI256307B - Methods of delivery compounds into a cell - Google Patents

Methods of delivery compounds into a cell

Info

Publication number
TWI256307B
TWI256307B TW86106635A TW86106635A TWI256307B TW I256307 B TWI256307 B TW I256307B TW 86106635 A TW86106635 A TW 86106635A TW 86106635 A TW86106635 A TW 86106635A TW I256307 B TWI256307 B TW I256307B
Authority
TW
Taiwan
Prior art keywords
cell
methods
delivery compounds
compound
delivery
Prior art date
Application number
TW86106635A
Other languages
Chinese (zh)
Inventor
Evan C Unger
Thomas Mccreery
Original Assignee
Imarx Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imarx Therapeutics Inc filed Critical Imarx Therapeutics Inc
Application granted granted Critical
Publication of TWI256307B publication Critical patent/TWI256307B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is directed, inter alia, to a method for delivering a compound into a cell comprising administering to the cell the compound to be delivered, an organic halide, and/or a carrier. Ultrasound may also be applied, if desired.
TW86106635A 1997-01-17 1997-05-15 Methods of delivery compounds into a cell TWI256307B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78566197A 1997-01-17 1997-01-17

Publications (1)

Publication Number Publication Date
TWI256307B true TWI256307B (en) 2006-06-11

Family

ID=37614621

Family Applications (1)

Application Number Title Priority Date Filing Date
TW86106635A TWI256307B (en) 1997-01-17 1997-05-15 Methods of delivery compounds into a cell

Country Status (1)

Country Link
TW (1) TWI256307B (en)

Similar Documents

Publication Publication Date Title
EP0935415A4 (en) Methods for delivering compounds into a cell
MX9700082A (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide.
EP1093819A3 (en) Compounds and compositions for delivering active agents
AU9021298A (en) Agmatine as a treatment for neuropathic pain
PL347671A1 (en) Compounds and compositions for delivering active agents
MY114014A (en) Imidazole compounds, compositions and use
DK0840621T3 (en)
HK1036970A1 (en) Compounds and compositions for delivering active agents.
MX9605023A (en) Imidazolidine-2,4-dione substituted compounds, as pharmaceutically active substances.
AU7031500A (en) Therapeutic quinazoline compounds
PL327735A1 (en) Novel substituted derivatives of imidazole
MXPA01008611A (en) Compounds and compositions for delivering active agents.
DE69311556D1 (en) INHALATION POWDER CONTAINING ANTISTATIC AUXILIARY AGENT
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
MX9800408A (en) Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts.
GB9907571D0 (en) Compounds
PL323145A1 (en) Transcutaneous therapeutic system (tts) for administering testosterone
MY124078A (en) Eletriptan hydrobromide monohydrate
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
TWI256307B (en) Methods of delivery compounds into a cell
AU8631698A (en) A process for the preparation of tetraazamacrocycles
NZ509198A (en) Treatment for multiple sclerosis using a histamine H2 agonist in combination with a phosphodiesterase inhibitor
ES2170377T3 (en) COMPOSITION CONTAINING QUITOSANA.
AU9294698A (en) Methods and compositions for enhanced wound healing

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees